Knowledge Hub

The infusion therapy industry is experiencing strong growth due to increasing demand for specialty biologics, chronic disease management, and a continued shift toward lower-cost outpatient and home-based care settings. M&A activity has accelerated as private equity firms and strategic buyers seek scalable platforms with specialty pharmacy integration, in-network payer contracts, and strong referral pipelines. Valuations tend to be highest for providers offering a broad therap